Werewolf Therapeutics, Inc. (HOWL) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$60.82M | +13.7% |
| 2024 | -$70.52M | -88.7% |
| 2023 | -$37.37M | +30.6% |
| 2022 | -$53.81M | -7.7% |
| 2021 | -$49.98M | -232.3% |
| 2020 | -$15.04M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$60.82M | +13.7% |
| 2024 | -$70.52M | -88.7% |
| 2023 | -$37.37M | +30.6% |
| 2022 | -$53.81M | -7.7% |
| 2021 | -$49.98M | -232.3% |
| 2020 | -$15.04M | — |